| MRTX YTD Return Table | ||||||||||||||||||||||||||||||
MRTX YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare MRTX YTD return (see YTD Return Meaning) versus benchmarks: YTD Return S&P YTD Return Dow YTD Return Nasdaq 100 YTD Return Russell 2000 YTD Return Gold YTD Return 10 Year Treasury YTD Return By Sector |
| MRTX Share Performance |
| MRTX YTD Return Chart | |||
Also see: MRTX Average Annual Return | |||
| About Mirati Therapeutics Inc |
| Mirati Therapeutics is a clinical-stage oncology company developing therapeutics to address the genetic and immunological promoters of cancer. Co.'s product candidates include: Adagrasib, an investigational, selective, specific, potent and orally available KRAS G12C inhibitor in clinical development as a monotherapy and in combination with other agents; MRTX1133, an investigational, selective, specific and potent KRAS G12D inhibitor in preclinical development; Sitravatinib, an investigational spectrum-selective kinase inhibitor; and MRTX1719, an internally discovered investigational synthetic lethal PRMT5 inhibitor to target the PRMT5/methylthioadensoine complex in preclinical development. The MRTX YTD return is shown above.
The YTD Return on the MRTX YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether MRTX YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the MRTX YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| MRTX Current Stock Quote |
 Free MRTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Mirati Therapeutics (MRTX) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
MRVI YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!